Literature DB >> 26438419

Computational modelling of atherosclerosis.

Andrew Parton, Victoria McGilligan, Maurice O'Kane, Francina R Baldrick, Steven Watterson.   

Abstract

Atherosclerosis is one of the principle pathologies of cardiovascular disease with blood cholesterol a significant risk factor. The World Health Organization estimates that approximately 2.5 million deaths occur annually because of the risk from elevated cholesterol, with 39% of adults worldwide at future risk. Atherosclerosis emerges from the combination of many dynamical factors, including haemodynamics, endothelial damage, innate immunity and sterol biochemistry. Despite its significance to public health, the dynamics that drive atherosclerosis remain poorly understood. As a disease that depends on multiple factors operating on different length scales, the natural framework to apply to atherosclerosis is mathematical and computational modelling. A computational model provides an integrated description of the disease and serves as an in silico experimental system from which we can learn about the disease and develop therapeutic hypotheses. Although the work completed in this area to date has been limited, there are clear signs that interest is growing and that a nascent field is establishing itself. This article discusses the current state of modelling in this area, bringing together many recent results for the first time. We review the work that has been done, discuss its scope and highlight the gaps in our understanding that could yield future opportunities.
© The Author 2015. Published by Oxford University Press. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  atherosclerosis; cardiovascular disease; cholesterol; computational biology; modeling; systems biology

Mesh:

Year:  2015        PMID: 26438419     DOI: 10.1093/bib/bbv081

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  6 in total

1.  WELL-POSEDNESS OF A MATHEMATICAL MODEL OF DIABETIC ATHEROSCLEROSIS WITH ADVANCED GLYCATION END-PRODUCTS.

Authors:  Xuming Xie
Journal:  Appl Anal       Date:  2022-04-06       Impact factor: 1.278

2.  Is systems pharmacology ready to impact upon therapy development? A study on the cholesterol biosynthesis pathway.

Authors:  Helen E Benson; Steven Watterson; Joanna L Sharman; Chido P Mpamhanga; Andrew Parton; Christopher Southan; Anthony J Harmar; Peter Ghazal
Journal:  Br J Pharmacol       Date:  2017-11-26       Impact factor: 8.739

3.  A Comparison of Fully-Coupled 3D In-Stent Restenosis Simulations to In-vivo Data.

Authors:  Pavel S Zun; Tatiana Anikina; Andrew Svitenkov; Alfons G Hoekstra
Journal:  Front Physiol       Date:  2017-05-23       Impact factor: 4.566

4.  Identification of potential crucial genes in monocytes for atherosclerosis using bioinformatics analysis.

Authors:  Yuan-Meng Zhang; Ling-Bing Meng; Si-Jun Yu; Dong-Xing Ma
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

5.  Location-Specific Comparison Between a 3D In-Stent Restenosis Model and Micro-CT and Histology Data from Porcine In Vivo Experiments.

Authors:  P S Zun; A J Narracott; C Chiastra; J Gunn; A G Hoekstra
Journal:  Cardiovasc Eng Technol       Date:  2019-09-17       Impact factor: 2.495

6.  Control of Cholesterol Metabolism Using a Systems Approach.

Authors:  Dorota Formanowicz; Marcin Radom; Agnieszka Rybarczyk; Krzysztof Tanaś; Piotr Formanowicz
Journal:  Biology (Basel)       Date:  2022-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.